Regions for Health Innovation: Personalised Medicine and ATMPs driving Europe’s Future
30.09.2025 - 15:00
30.09.2025 - 19:30
European Parliament, Brussels. Room SPINELLI 3G3
Biocat, PRECISEU. With the support of Generalitat de Catalunya.
The European Parliament will host the event “Personalised Medicine: Driving European Competitiveness with Regional Leadership”, a high-level meeting aimed at highlighting the role of personalised medicine and regions as drivers of innovation and competitiveness in Europe.
The event is sponsored by Biocat, supported by the Government of Catalonia, framed within the European project PRECISEU, and hosted by MEP Nicolás González Casares, Socialists & Democrats Group of the European Parliament.
During the session, which will bring together Members of the European Parliament, representatives of the European Commission, regional authorities and industry experts, key strategic issues will be discussed, including:
- The role of personalised medicine in Europe’s competitiveness.
- The importance of regions in fostering innovation and growth.
- The impact of the Pharma Package and European health legislation.
- Regional experiences and initiatives driving EU’s competitiveness.
The event will conclude with a networking reception at the European Parliament, fostering collaboration among political, scientific, industrial and institutional stakeholders.
Presenters of the session: María Cejas, Biocat
Registration link
More information: preciseu@biocat.cat
Agenda
- Honorable Member of the European Parliament
- Dr Robert Fabregat. CEO of Biocat
- Sra. Ester Borràs, Delegate. the Catalan Government to the European Union
Dr. Rainer Beoker. Director D., Medical products and innovation. DG SANTE
Chair and final key messages:
- Dr. Montse Daban, Director of Strategic Foresight and International Relations. Biocat / Coordinator. PRECISEU
Speakers:
- Dr. Aneta Tyszkiewicz, Director, Digital & Data for the Science Policy and Regulatory Affairs team. EFPIA / Member. PRECISEU Advisory Board.
- Dr. Christopher Mann, Scientific & Regulatory Director. Asphalion
- Mr. Pedro Carrascal, Director General. Platform of Patients’ Organisations (POP)
Chair and final key messages:
- Dr. David Morrow, Scientific Lead Advanced Therapies. EATRIS
Speakers:
- Dr. Kathleen d’Hont, Policy Advisor Department Work, Economy, Science, Innovation, Social Economy (WEWIS). Flemish Government
- Dr. Antoni Plasencia, Director General for Research and Innovation. Ministry of Health, Government of Catalonia
- Dr. Jim Lund, Chief Business Development Officer. CCRM Nordic
Chair and final key messages:
- Ms. Ewa Chomicz, Policy and Engagement Manager. the European Regions Research and Innovation Network (ERRIN)
Speakers:
- Dr. Jekaterina Novikova, Deputy Head of Unit. DG RTD Innovation Policy and Access to Finance unit.
- Mr. Aleix Cubells Barceló, Director General EU Funds and State Aids. Government of Catalonia
- Ms. Delia Solá, Director of Support Services. European Initiatives, Government of Navarra / Coordinator. RIV ECIV
“A Fundamental Term Ahead for Health Innovation – The Biotech Act”
Dr. Claire Skentelbery, Director General at EuropaBio. the European Association for Bioindustries
“Biotechnology for Human Health: The Debate in the European Parliament”
Mr. Nicolás González Casares, Hon. MEP. European Parliament
- Mrs. Laura Ballarín Cereza, Hon. MEP. the European Parliament
- Mr. Nicolás González Casares, Hon. MEP. the European Parliament
- Mr. Francesc Trillas Jané, Secretary for Economic Affairs and European Funds. the Catalan Government
Informal networking with refreshments
